Overview

Effect of LIK066 on Body Weight in Patients With Elevated Body Mass Index

Status:
Completed
Trial end date:
2016-04-04
Target enrollment:
Participant gender:
Summary
A 12-week study to assess LIK066 effect on body weight in diabetics, prediabetics and normoglycemic patients with elevated body mass index (BMI)
Phase:
Phase 2
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Licogliflozin